MSB 12.1% 55.5¢ mesoblast limited

The way I see FDA's major concern, demonstration of consistent...

  1. 3,753 Posts.
    lightbulb Created with Sketch. 1268
    The way I see FDA's major concern, demonstration of consistent batch to batch effectiveness , they are not convinced that MSB batch testing demonstrates a consistent product. Problem is if MSB were to test this in a clinical setting, some patients would have to receive substandard product that may result in death.

    I believe that the problem of batch consistency is reasonably easy to monitor and would address the concerns of the FDA . Run a patient data base with key outcomes and monitor for a period of time. The solution is that simple and is what these meetings are all about.

    Common sence will prevail,
    good luck.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
7 99223 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 44000 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 28/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.